Company / Total Debt
Adaptive Biotechnologies Corp Total Debt History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$126.6M
FY2025
5-year range
$125.4M / $132.4M
FY2022-FY2025
Trend
-4.4%
vs FY2024
Sector context
#50 of 83
Health Care
What the data says
At $127M, Adaptive Biotechnologies Corp's total debt ranks #34 of 83 in the Health Care sector. Total Debt remained relatively stable over the past 4 years, with values between $125M and $132M.
Based on SEC 10-K filings.
$127M in FY2025 with a 3-year CAGR of +0.3%.
Improved from $131M to $127M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +0.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#34 of 83 in Health CareTop 40% of 83This company $126.6M Sector average $6.2B
▼
-97.9% below sector average
Key checks
Key Insights
- 3-year CAGR of +0.3%, indicating consistent growth.
- In FY2025, total debt decreased 4.4% year-over-year.
- Ranks #50 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $126.6M | -4.4% |
| FY2024 | $132.4M | +1.3% |
| FY2023 | $130.7M | +4.2% |
| FY2022 | $125.4M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026